IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,748,990 | +33.8% | 146,136 | -17.2% | 0.21% | +20.1% |
| Q1 2023 | $4,295,291 | -54.4% | 176,543 | -59.9% | 0.17% | -62.4% |
| Q4 2022 | $9,428,493 | +1428.1% | 440,378 | +1179.9% | 0.46% | +1496.6% |
| Q3 2022 | $617,000 | -70.2% | 34,407 | -84.0% | 0.03% | -71.3% |
| Q2 2022 | $2,070,000 | -74.4% | 215,215 | -55.2% | 0.10% | -72.6% |
| Q1 2022 | $8,090,000 | +186.5% | 480,707 | +184.6% | 0.37% | +136.5% |
| Q4 2021 | $2,824,000 | +392.8% | 168,913 | +379.0% | 0.16% | +437.9% |
| Q3 2021 | $573,000 | – | 35,263 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |